Is MicroVision Stock Overvalued Or Undervalued? It's Significantly Overpriced

Aug. 19, 2022 11:18 AM ETMicroVision, Inc. (MVIS)LAZR, MOON, VLDR73 Comments


  • MicroVision shares blasted off during the 2021 meme stock moment.
  • However, the company's fundamentals remain uninspiring and shares appear to be dramatically overvalued.
  • With almost no revenues coming in, MicroVision has to resort to unending share dilution to keep operations going.
  • Looking for a helping hand in the market? Members of Ian's Insider Corner get exclusive ideas and guidance to navigate any climate. Learn More »

Top view of self-driving SUV on the road with sensing graphic pattern retouched


MicroVision (NASDAQ:MVIS) is a small technology company that has attempted to commercialize a variety of different ideas. Currently, the company's primary focus is on light detection and ranging "lidar" systems, which are used in autonomous vehicles.

For a while, MicroVision was one of the only publicly-traded lidar stocks in the United States, giving it appeal and a sort of scarcity value on this technology. However, with the SPAC boom, a number of larger and better funded competitors such as Luminar Technologies (LAZR) came to market.

That being the case, interest in MicroVision has diminished recently, and the share price has slipped. Is there hope for a turnaround? Unfortunately, even at the lower share price, MVIS stock remains overvalued and highly risky going forward.

MVIS Stock Key Statistics

MicroVision was founded in 1993. What has the company accomplished over the years? According to the company's 10-K, MicroVision has created all sorts of proprietary products and technologies:

"Throughout our history, we have combined our proprietary technology with our development expertise to create innovative solutions to address existing and emerging market needs, such as augmented reality microdisplay engines; interactive display modules; consumer lidar components; and, most recently, automotive lidar sensors and solutions for the automotive market."

Sounds promising, right? Yet, when we turn to MicroVision's most important stat - revenues - we find a major shortcoming:

Data by YCharts

Over the past decade, MicroVision has never produced more than $20 million of revenue in a single year. Even the relative success of 2018 would soon disappear as revenues dropped from a peak of $17 million to less than $2 million last year.

Is MicroVision Overvalued?

In a word: Yes.

MicroVision has a market cap of $845 million against less than $2 million of projected 2022 revenues. The company hasn't produced an operating profit for even one year out of the past decade. And its past product launches routinely underwhelm.

Here's former MicroVision CEO Perry Mulligan talking up interactive displays in July 2019:

"Consequently, we now expect Display-only and Interactive Display products could launch in mid-2020, with first revenue to us likely starting in Q2 2020 and the potential for profitability, depending on volumes and product mix considerations, one quarter later,"

Mulligan suggested that the company could be profitable by the end of 2020. Instead, MicroVision produced almost no revenues at all in 2020, from displays or otherwise, and came up with a large operating loss like usual. After more than twenty years as a publicly-traded company, MicroVision needs to deliver actual results rather than just an encouraging narrative.

Is MicroVision Expected To Go Up?

Some traders believe MicroVision shares should rally due to high short interest.

There is some precedence for this. MVIS shares rose spectacularly in 2021 during the Reddit/WallStreetBets meme stock phenomenon, with shares going from the pennies to $25 at one point:

Data by YCharts

On message boards and social media, unsubstantiated rumors went around suggesting that MicroVision was about to win major contracts or be a buyout target for a larger tech company such as Nvidia (NVDA).

Some disruption-themed ETFs also piled into MicroVision shares amid the excitement. The Direxion Moonshot Innovators ETF (MOON), for example, made MVIS stock one of its top holdings.

When nothing came of this chatter, however, shares quickly crashed. And, though meme stock excitement has bubbled up again lately in stocks such as Bed Bath & Beyond (BBBY), as of yet, there's been little sign of any similar rekindling of interest in MicroVision.

Bulls can point to the fact that 26% of MVIS stock's float is currently sold short. And short sellers are paying a high fee to borrow shares, currently 18% per year at Interactive Brokers, for example. However, high short interest is often a sign that a company's prospects are dim. Bears rarely press bets against a company to this extent unless they're quite confident that shares will trade lower in the future.

All that to say that MicroVision could enjoy another short squeeze if the right combination of press releases or positive social media chatter occurred again. However, traders banking on a repeat of the early 2021 excitement in MicroVision stock should be careful. There simply is very little in the company's fundamentals which would justify such a move.

Is MicroVision Stock A Good Long-Term Investment?

No, MicroVision is not suitable for long-term investment. The company hasn't generated an operating profit even a single time over the past decade. Its ability to generate revenues is also questionable at best.

While the company's operations and new products rarely encounter much success, the company continues to suffer from high overhead expenses.

The company has lost at least $13 million from operations each year of the past decade. Losses accelerated to an eye-watering $44 million last year. Since the company does not generate meaningful sales, let alone profits at the moment, it has to fund these widening operating losses via stock sales.

In fact, MicroVision has piled up a track record of massive share dilution:

Data by YCharts

Since 2013, the company's shares outstanding have surged from around 30 million to more than 165 million today. A shareholder that has held the stock for the past decade has now been diluted to less than 20% of their original ownership position. If the company was putting all this new share capital to good use, that would be one thing. But there's little evidence of shareholder value creation being accomplished by any of the company's recent business ventures.

MicroVision shares peaked back at a split-adjusted $510 per share in 2000. It's now down 99% since that point. And, over the decades, MicroVision has piled up an accumulated deficit of $656 million, meaning that it's blown through more than half a billion dollars with little to show for it. At some point, investors may want to consider not giving this company any more funding.

Is MVIS Stock A Buy, Sell, Or Hold?

Given the above facts, it's probably not surprising that I rate MVIS stock a sell.

Incredibly enough, MicroVision still has a market cap of more than $800 million despite producing virtually no revenues and not having any track record of commercial success. For comparison's sake, Velodyne Lidar (VLDR) is producing more than $40 million in annual revenues and has a market cap of just $320 million today.

Do I think Velodyne is a promising investment? No, not especially. But at least it has proven there is some commercial demand for its products. MicroVision, by contrast, has little more than prototypes and press releases to point to. As such, MVIS stock's $800 million valuation is rather ambitious.

If you enjoyed this, consider Ian's Insider Corner to enjoy access to similar initiation reports for all the new stocks that we buy. Membership also includes an active chat room, weekly updates, and my responses to your questions.

This article was written by

Ian Bezek profile picture
Research and trade alerts from a hedge fund pro with a global outlook.

Ian worked for Kerrisdale, a New York activist hedge fund, for three years, before moving to Latin America to pursue entrepreneurial opportunities there. His Ian's Insider Corner service provides live chat, model portfolios, full access and updates to his "IMF" portfolio, along with a weekly newsletter which expands on these topics.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (73)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.